The 'Dispatched' Podcast
BioPharmaDispatch - discussing the issues impacting the Australian biopharmaceutical and life sciences sectors with Paul Cross and Felicity McNeill.
The 'Dispatched' Podcast
Latest Episodes
The 'Dispatched' Podcast - Series 5. Ep.36
Welcome to the first podcast video recording. Recorded at the recent Pfizer Invites event, this episode focuses on the rapidly emerging private market and whether it can catalyse meaningful medicines reform to benefit patients who are either wa...
The 'Dispatched' Podcast Week in Review - Series 5. Ep.35
Should industry groups present the agreement negotiations to patient groups and 'invited' stakeholders, and if so, what should they say? Why the private market for GLP-1 medicines could be a historic catalyst for the changes so many want.
The 'Dispatched' Podcast Week in Review - Series 5. Ep.34
The impact of new media guidance from Australia's health technology regulator can now be assessed against the backdrop of its use of an AI platform initially developed for, and still used by, intelligence and law enforcement agencies. Why is th...
The 'Dispatched' Week in Review - 25 September
A week dominated by discussions about AI that was all of good, less good, self-serving and ironic. Surely we can grasp the opportunity while managing the risks. A dehumanising outcome for women living with a form of advanced breast cancer must ...
The 'Dispatched' Week in Review - 11 September
This week, we mark a significant anniversary, discuss the risks of missing the opportunity that artificial intelligence offers to speed access to healthcare, and explore why some might be reluctant to embrace it. The wonderful irony of the phra...